Ressource Scientifique
Poster

Tumor-specific molecular changes in luminal B breast cancer patient-derived xenografts (PDXs) with acquired resistance to endocrine treatment
In this study we describe establishment of a luminal breast cancer PDX model with acquired resistance to hormonotherapy

Development of an immunogenicity assay for Anti Drug Antibody (ADA)
Immunogenicity assessement for the detection of ADA (Anti Drug Antibody) directed against CpG-D35 using ECL technology (MSD) in serum samples.

NANOCYCLIX® ALK2 INHIBITORS TO OVERCOME CANCER INDUCED ANEMIA
NANOCYCLIX® ALK2 INHIBITORS TO OVERCOME CANCER INDUCED ANEMIA

Novel fluorescent probes evaluated in an orthotopic pancreatic PDX model
Novel fluorescent probes evaluated in an orthotopic pancreatic PDX model

Bioanalytical challenges with BioChaperone® BC structures
We wish to develop and validate LC-MS/MS methods for the quantitation of both BioChaperone® BCXXX (Parent) and its truncated metabolite BCYYY inSprague-Dawley rat, Beagle dog and human plasma following the current international guidelines for industry?